Alexandra Drakaki,医学博士
接受新病人

Alexandra Drakaki,医学博士

(她/她)
  • 医学肿瘤学
平均评级: 5.0
| 229 评级
 
圣莫尼卡癌症护理中心 | 2020圣莫尼卡大道, 580套房, 圣塔莫尼卡, CA 90404

关于

Alexandra Drakaki is an MD, PhD and Associate Professor of 血液学/Oncology and 泌尿外科. She received her training in Internal Medicine at a Tuft's University affiliate program while she completed her 血液学 / Oncology training at Beth Israel Deaconess Medical Center at Harvard Medical School and her research fellowship at Dana Farber 癌症中心 Harvard Medical School in Boston. She specializes in Genitourinary cancers and specifically cancers of the Bladder, 肾脏, 前列腺和睾丸.

She is the Primary Investigator in therapeutic clinical trials as well as the Lead investigator in a national level in studies that are testing novel drugs. Her research interest is studying the role of a class of genes, 命名为非编码rna, including microRNAs and linkRNAs in genitourinary malignancies. She also has a special interest in studying and understanding the mechanism of drug related toxicity with goal to find combinations of medications that reverse/prevent toxicity without stopping effective therapies.

She is part of the Translational Oncology 研究 Laboratory of the globally renowed Dr. Slamon, in which researchers are working on drug development by using novel technologies for breakthrough discoveries to treat cancer.

语言

英语

教育

医学委员会认证

医学肿瘤学, American Board of Internal Medicine, 2013
血液学, American Board of Internal Medicine, 2013
Internal Medicine, American Board of Internal Medicine, 2010

奖学金

血液学 & Oncology, Beth Israel Deaconess Med Ctr-East Campus, 2013

住院医生实习期

内科,圣. Elizabeth's Medical Center, 2010

实习

内科,圣. 伊丽莎白医疗中心,2008年

学位

克里特岛大学医学博士,2006年

医院关系

研究

利益

Dr. Drakaki's research interest is understanding the role of small non coding RNAs in oncogenesis which was also the focus of her PhD. She is currently working on identifying the mechanism by which specific microRNAs are involved in genitourinary malignancies. She is also the primary investigator of several clinical trials that lead to breakthrough approval of novel drugs in the field.

Dr. Drakaki has a special interest in understanding the mechanism of drug toxicity and specifically immune mediated side effects. She is working on developing combinations of medication that can prevent/reverse autoimmunity without needing to stop cancer directed therapy.

皇冠hga025报道

保险

  • 安泰
  • 圣歌蓝十字
  • 皇冠hga025蓝盾公司
  • Centivo
  • 信诺
  • 第一届卫生
  • 皇冠hga025健康网
  • Interplan (HealthSmart的一部分)
  • L.A. 护理
  • MultiPlan
  • UFCM健康系统
  • 初级保健服务
  • Private Healthcare Systems (PHCS)
  • TRICARE
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.

认识

  • 超级医生®南皇冠hga025,2024年
  • 前 Doctors, Los Angeles Magazine, 2023
  • 前 Doctors, Los Angeles Magazine, 2022
  • Nomination for The Faculty Mentor Award for the Internal Medicine Program, UCLA, 2022
  • 前 Doctors, Los Angeles Magazine, 2021
  • Exceptional Physician for the UCLA health System Nomination, 2020
  • Best Attending Teaching Award, Teacher of the Year, 血液学/Oncology, UCLA, 2020
  • 超级医生®南皇冠hga025,2018
  • Merit Award at the GU ASCO, 2018
  • Rising Star, 超级医生 in Southern California, 2016, 2017
  • Best Attending Teaching Award, Teacher of the Year, 血液学/Oncology, UCLA, 2016
  • Merit Award in the Gastrointestinal Cancers Symposium, GI ASCO, 2013
  • Merit Award at the GI ASCO, 2013
  • Best Teaching Award for Residents, Tufts University 医学院, MA, 2010
  • Best Basic 研究 Award for Residents and Fellows in National Annual American College of Physicians Meeting, 2009
  • National American College of Physician Award, 2009
  • Best 研究 Award for Residents and Fellows, Annual American College of Physicians Meeting, 麻萨诸塞州, 2008
  • Local American College of Physician Award at the state of 麻萨诸塞州, 2008
  • Award for Best Medical Student, 2003